For a disease afflicting 35.5 million people in the U.S., chronic kidney disease flies under the radar. Only half the people ...

revealing its potential as a biomarker to predict chronic kidney disease progression. A repurposed anti-cancer drug, ... One in 3,000 People at Risk of Punctured Lung from Faulty Gene -- Almost ...

In March, two biotechnology companies were given the greenlight by the Food and Drug Administration, or FDA, to conduct ...

Researchers have identified type 5 collagen as a key factor in kidney fibrosis, revealing its potential as a biomarker to predict chronic kidney disease progression. A repurposed anti-cancer drug, ...

Employment among patients with kidney disease remains low even after dialysis or a transplant, with physical and social ...

University of Pittsburgh Medical School researchers walk us through multiple approaches they’ve tried in the past, are currently using or plan to use in the future, as well as the significant ...

Tirzepatide improves kidney function and cardiovascular outcomes in patients with obesity and heart failure with preserved ejection fraction (HFpEF), regardless of chronic kidney disease status.

Tirzepatide offers a promising treatment for patients with obesity, chronic kidney disease, and heart failure, improving both ...

Deficiency of the pancreatic progenitor cell differentiation and proliferation factor gene was identified as a risk factor ...

In patients with heart failure with preserved ejection fraction and obesity, tirzepatide improved clinical outcomes compared ...

COVID-19 was linked to a faster annual decline in kidney function than pneumonia, prompting study authors to call for closer ...

Kidney failure affects millions worldwide, and the number keeps rising. Each year, the global population of patients with end ...